Refine by MP, party, committee, province, or result type.

Results 31-45 of 94
Sorted by relevance | Sort by date: newest first / oldest first

May 15th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  Thank you both for being here. Dr. Croft, as I listened to your testimony and some of the questions you were just answering, I couldn't help but think of the precautionary principle.

May 15th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  When I think of 280 people taking medication and two of them having that kind of episode, I have to be honest. I'm not willing to risk any of the men and women in uniform in this country—

May 15th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  —in that way. One of the things you said in your testimony is that in the army, you do what you're told. I would like you to just share a little about that and the impacts that could have on the people who have served our country. The Conservative member that you talked to earl

May 15th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  Thank you for that. You talked about the profile—and I hope I'm getting this right because I'm definitely not a physician—of the neuropsychiatric impact. I'm just wondering if you could explain what that means, compare it to the other medications that you can take for malaria an

May 15th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  Thank you so much.

May 13th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  Thank you so much. Those are all the questions I have.

May 13th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  I just want to go back to Dr. Quinn to clarify something for the record. In Australia now there's an official diagnosis for mefloquine use. Is that the case?

May 13th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  Thank you so much. I appreciate that. The last thing I want to come back to is the lack of conferences or work being done on this internationally. What we're often seeing here in Canada, and what it sounds like you're seeing there in Australia as well, is that veterans are comin

May 13th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  Thank you. Dr. Sellers, is there anything you'd like to add?

May 13th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  Thank you. I think that's my time.

May 13th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  I have just a couple of questions.

May 13th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  One of the things that occurs to me as we do this study is the reality of the particular group of people we're talking about here. One question that's come up a couple of times is: Are we making sure that our armed forces have informed decision-making about medication that they'r

May 13th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  Thank you so much. I really appreciate that. Dr. Quinn, I will turn to you. Right now in Canada there's no real process for Veterans Affairs or even National Defence to reach out to people who have taken mefloquine. There's no process for them to screen, so one of the concerns t

May 13th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  Thank you so much. Definitely what we've heard from many veterans across Canada is that piece about being acknowledged and that their feelings of stress and disenfranchisement are because their having this disorder is not not being acknowledged. Dr. Sellers, is there anything yo

May 13th, 2019Committee meeting

Rachel BlaneyNDP